4//SEC Filing
Flowers Lee 4
Accession 0001209191-23-036087
CIK 0001828673other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 8:00 PM ET
Size
8.7 KB
Accession
0001209191-23-036087
Insider Transaction Report
Form 4
Flowers Lee
SVP of Business Development
Transactions
- Exercise/Conversion
Common Stock
2023-06-08$0.14/sh+5,356$750→ 101,308 total - Purchase
Common Stock
2023-06-08$2.16/sh+10,000$21,574→ 111,308 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-06-08−5,356→ 7,501 totalExercise: $0.14Exp: 2029-09-18→ Common Stock (5,356 underlying)
Footnotes (1)
- [F1]20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023.
Documents
Issuer
HCW Biologics Inc.
CIK 0001828673
Entity typeother
Related Parties
1- filerCIK 0001866254
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 8:00 PM ET
- Size
- 8.7 KB